Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$239K Sell
3,546
-816
-19% -$54.4K 0.01% 571
2026
Q1
$274K Buy
+4,362
New +$304K 0.02% 495
2024
Q2
Sell
-1,759
Closed -$246K 372
2024
Q1
$246K Sell
1,759
-1,876
-52% -$236K 0.02% 274
2023
Q4
$453K Buy
+3,635
New +$371K 0.05% 192
2023
Q1
Sell
-1,791
Closed -$205K 232
2022
Q4
$205K Buy
+1,791
New +$197K 0.03% 199

Other funds holding DXCM

Certuity's DXCM Position: Q2 2026 in Review

Certuity reduced its DexCom (DXCM) stake by 19% in Q2 2026, selling an estimated $54.4K and leaving 3,546 shares worth $239K. The position accounts for 0.01% of the portfolio, ranked #571.

Certuity first reported a position in DXCM in Q4 2022 and has held it in 5 quarters since. The position peaked at $453K in Q4 2023. 313 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Certuity held 3,546 shares of DexCom worth $239K as of Q2 2026.
  • Certuity sold 816 DexCom shares in Q2 2026, an estimated $54.4K.
  • DexCom made up 0.01% of Certuity's portfolio in Q2 2026, its #571 holding.
  • Certuity first reported a position in DexCom in Q4 2022 and has held it in 5 quarters since.
  • Certuity's DexCom position peaked at $453K in Q4 2023.
  • 313 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Certuity's 13F filing for Q2 2026, filed 28 Jul 2026.